Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder:a systematic review and meta-analysis. BMC Psychiatry 20, 121 (2020). https://doi.org/10.1186/s12888-020-2477-9
Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders Journal of the American Academy of Child & Adolescent Psychiatry Available online 6 May 2020 https://doi.org/10.1016/j.jaac.2020.03.007
The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records. J Clin Psychiatry. 2017 Nov/Dec;78(9):e1233-e1241. doi: 10.4088/JCP.16m11422.
Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder Front Genet. 2020; 11: 308. https://dx.doi.org/10.3389%2Ffgene.2020.00308
Efficacy and Safety of Fluoxetine in Autism Spectrum Disorder: A Meta-analysis. American Journal of Therapeutics: May/June 2020 - Volume 27 - Issue 3 - p e312-e315 doi: 10.1097/MJT.0000000000000978
Punding Related to Methylphenidate–Aripiprazole Combination in a Hyperkinetic Low-Functioning Autism Spectrum Disorder Child American Journal of Therapeutics: May 26, 2020 - Volume Publish Ahead of Print - Issue - doi: 10.1097/MJT.0000000000001201
Pharmacotherapy in Autism Spectrum Disorder: How, When and Why. Vol 11, No 1Sup1 (2020) http://dx.doi.org/10.18662/brain/11.1Sup1/28
Hirsch LE, Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews 2016, Issue 6. Art. No.: CD009043. DOI: 10.1002/14651858.CD009043.pub3